kratom 7-OH-mitragynine
Selected indexed studies
- A Case of 7-OH Mitragynine Use Requiring Inpatient Medically Managed Withdrawal. (J Addict Med, 2025) [PMID:40758956]
- The respiratory depressant effects of mitragynine are limited by its conversion to 7-OH mitragynine. (Br J Pharmacol, 2022) [PMID:35297034]
- Testing for Kratom alkaloids in fingernail clippings - not only mitragynine. (J Pharm Biomed Anal, 2024) [PMID:38489958]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Kratom: a primer for pain physicians. (2024) pubmed
- A Case of 7-OH Mitragynine Use Requiring Inpatient Medically Managed Withdrawal. (2025) pubmed
- The respiratory depressant effects of mitragynine are limited by its conversion to 7-OH mitragynine. (2022) pubmed
- Testing for Kratom alkaloids in fingernail clippings - not only mitragynine. (2024) pubmed
- De facto opioids: Characterization of novel 7-hydroxymitragynine and mitragynine pseudoindoxyl product marketing. (2025) pubmed
- Quantification of 11 kratom alkaloids including mitragynine and its main metabolites in human plasma using LC-MS/MS. (2025) pubmed
- Clinical Pharmacology of the Dietary Supplement Kratom (Mitragyna speciosa). (2022) pubmed
- Kratom: A growing substance of abuse in the United States. (2020) pubmed
- Kratom as a novel cause of photodistributed hyperpigmentation. (2022) pubmed
- Determination of Mitragynine in Mitragyna speciosa Raw Materials and Finished Products by Liquid Chromatography with UV Detection: Single-Laboratory Validation. (2017) pubmed